MDM2/XIAP-IN-1 (compound 14) is an orally active dual inhibitor of MDM2 and XIAP, displaying anti-cancer activity with an IC50 of 0.3 µM and potential applications in cancer research [1].
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
